DRUG FACTS

Drug Labeling and Warnings

Drug Details [pdf]

TUSSI PRES- guaifenesin, phenylephrine hydrochloride, dextromethorphan hydrobromide syrup 
Kramer Novis

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRUG FACTS

Active Ingredients per 5 ml: Guaifenesin 200 mg, Phenylephrine HCL 5 mg, Dextromethorphan HBr 10 mg

COUGH SUPPRESSANT

NASAL DECONGESTANT

EXPECTORANT

Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

temporarily relieves these symptoms occurring with cold:

nasal congestion

cough due to minor throat and bronchial irritation

Do Not Use: in a child under 2 years of age

if you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain

drugs for depression, psychiatric, or emotional conditions, or Parkinson’s

disease), or for 2 weeks after stopping the MAOI drug. If you do not know if

your prescription drug contains an MAOI, ask a doctor or pharmacist before

taking this product. 

Ask a doctor before use if you have heart disease, thyroid disease, high blood pressure, diabetes

trouble urinating due to enlargement of the prostate gland

cough that occurs with too much phlegm (mucus)

chronic bronchitis or emphysema

When using this product, do not exceed recommended dosage

Stop use and ask a doctor if

you get nervous, dizzy, or sleepless

symptoms do not get better within 7 days or are accompanied by fever

cough lasts more than 7 days, comes back, or is accompanied by fever,

rash, or persistent headache. These could be signs of a serious condition

adults and children 12 years and over 10mL (2 tsp) every 4 hours

children 6 to under 12 years 5mL (1 tsp) every 4 hours

children 2 to under 6 years 2.5mL (1/2 tsp) every 4 hours

under 2 years do not use

do not take more than 6 doses in any 4 hour period

If pregnant or breast feeding, ask a health professional before use

Keep out of reach of children

Inactive Ingredients:

citric acid,red 40,glycerin,methylparaben,potassium sorbate,propylene glycol,propylparaben,purified water,sodium citrate,sucralose

tussi pres 1,4,16 ounce labels

TUSSI PRES 
guaifenesin, phenylephrine hydrochloride, dextromethorphan hydrobromide syrup
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 52083-233
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg  in 5 mL
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE5 mg  in 5 mL
DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE10 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
Product Characteristics
Colorred (CHERRY RED) Score    
ShapeSize
FlavorCHERRY (SOUR CHERRY) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 52083-233-0130 mL in 1 BOTTLE; Type 0: Not a Combination Product03/28/2011
2NDC: 52083-233-04120 mL in 1 BOTTLE; Type 0: Not a Combination Product03/28/2011
3NDC: 52083-233-16480 mL in 1 BOTTLE; Type 0: Not a Combination Product03/28/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34103/28/201110/30/2019
Labeler - Kramer Novis (090158395)
Registrant - Kramer Novis (090158395)
Establishment
NameAddressID/FEIBusiness Operations
Ultra Seal Corporation085752004repack(52083-233)
Establishment
NameAddressID/FEIBusiness Operations
ULTRAtab Laboratories, Inc.151051757manufacture(52083-233)

Revised: 10/2019
 <

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.